Found: 28
Select item for more details and to access through your institution.
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 573, doi. 10.1002/ajh.22048
- By:
- Publication type:
- Article
Activation of NF-KB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
- Published in:
- Oncogene, 2002, v. 21, n. 37, p. 5673, doi. 10.1038/sj.onc.1205664
- By:
- Publication type:
- Article
Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays.
- Published in:
- Oncogene, 2002, v. 21, n. 9, p. 1346, doi. 10.1038/sj.onc.1205205
- By:
- Publication type:
- Article
The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applications.
- Published in:
- Oncogene, 2001, v. 20, n. 33, p. 4519, doi. 10.1038/sj.onc.1204623
- By:
- Publication type:
- Article
Emerging Trends in the Clinical Use of Bortezomib in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 84
- By:
- Publication type:
- Article
Novel Therapeutic Avenues in Myeloma: Changing the Treatment Paradigm.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 785
- By:
- Publication type:
- Article
New Treatments for Multiple Myeloma.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 14, p. 1781
- By:
- Publication type:
- Article
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 351, doi. 10.1111/bjh.12152
- By:
- Publication type:
- Article
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settings.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 6, p. 755, doi. 10.1111/j.1365-2141.2011.08791.x
- By:
- Publication type:
- Article
Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 4, p. 420, doi. 10.1111/j.1365-2141.2010.08427.x
- By:
- Publication type:
- Article
research paper Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 3, p. 343, doi. 10.1111/j.1365-2141.2004.04929.x
- By:
- Publication type:
- Article
Viral antigen-specific CD8<sup>+</sup> T-cell responses are impaired in multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 6, p. 842, doi. 10.1046/j.1365-2141.2003.04375.x
- By:
- Publication type:
- Article
New Drugs for Myeloma.
- Published in:
- Oncologist, 2007, v. 12, n. 6, p. 664, doi. 10.1634/theoncologist.12-6-664
- By:
- Publication type:
- Article
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 5, p. 446, doi. 10.1111/j.1600-0609.2012.01765.x
- By:
- Publication type:
- Article
The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 1, p. 1, doi. 10.1111/j.1600-0609.2011.01721.x
- By:
- Publication type:
- Article
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 222, doi. 10.1111/bjh.15261
- By:
- Publication type:
- Article
Patient‐reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double‐blind, placebo‐controlled PANORAMA‐1 trial.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 5, p. 628, doi. 10.1111/bjh.15248
- By:
- Publication type:
- Article
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 66, doi. 10.1111/bjh.14821
- By:
- Publication type:
- Article
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 843, doi. 10.1111/bjh.13382
- By:
- Publication type:
- Article
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 851, doi. 10.1111/bjh.13383
- By:
- Publication type:
- Article
Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 1, p. 127, doi. 10.1111/bjh.12925
- By:
- Publication type:
- Article
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 401, doi. 10.1111/bjh.12909
- By:
- Publication type:
- Article
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
- Published in:
- Nature Medicine, 2010, v. 16, n. 4, p. 483, doi. 10.1038/nm.2112
- By:
- Publication type:
- Article
MGUS and Smoldering Myeloma: the Most Prevalent of Plasma Cell Dyscrasias.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 594
- By:
- Publication type:
- Article
Tailoring Treatment for Multiple Myeloma Patients With Relapsed and Refractory Disease.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 22
- By:
- Publication type:
- Article
Bortezomib in the management of multiple myeloma.
- Published in:
- Cancer Management & Research, 2009, v. 1, p. 107
- By:
- Publication type:
- Article
Emerging Treatment Options in the Management of Multiple Myeloma.
- Published in:
- Journal of Managed Care Medicine, 2013, v. 16, n. 1, p. 25
- By:
- Publication type:
- Article